E-LIB Suche - Ergebnisse für: Ohtsuki, Mamitaro

1

Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Effi..:

Armstrong, April W. ; Lebwohl, Mark ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 4 - p. s406 , 2024

Link: https://doi.org/10.25251..

2

Safety and effectiveness of apremilast in Japanese patients..:

Ohtsuki, Mamitaro ; Okubo, Yukari ; Saeki, Hidehisa...
The Journal of Dermatology. 51 (2024) 7 - p. 950-963 , 2024

Link: https://doi.org/10.1111/..

3

A case of chronic pruritus developing at a noninjured nerve..:

Adachi, Akimasa ; Komine, Mayumi ; Murata, Satoru.
JEADV Clinical Practice. , 2024

Link: https://doi.org/10.1002/..

4

Incidental computed tomography findings in patients with ps..:

Sugihara, Natsuko ; Kamiya, Koji ; Kado, Soichiro...
Journal of Cutaneous Immunology and Allergy. 7 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

5

Deucravacitinib, an oral, selective, allosteric tyrosine ki..:

Imafuku, Shinichi ; Okubo, Yukari ; Tada, Yayoi...
The Journal of Dermatology. 51 (2024) 3 - p. 365-379 , 2024

Link: https://doi.org/10.1111/..

6

Deucravacitinib in Plaque Psoriasis: 3-year Safety and Effi..:

Armstrong, April W. ; Lebwohl, Mark ; Warren, Richard B....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 2 - p. s366 , 2024

Link: https://doi.org/10.25251..

7

A case of bullous pemphigoid developing after ixekizumab th..:

Sugihara, Natsuko ; Kamiya, Koji ; Nakano, Naomi...
The Journal of Dermatology. 50 (2023) 6 - p. , 2023

Link: https://doi.org/10.1111/..

8

43928 Long-term Safety and Efficacy of Risankizumab for the..:

Papp, Kim A. ; Lebwohl, Mark G. ; Puig, Lluís...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB62 , 2023

Link: https://doi.org/10.1016/..

9

Real‐world retention rates and effectiveness of secukinumab..:

Tada, Yayoi ; Morita, Akimichi ; Yamanaka, Keiichi...
The Journal of Dermatology. 50 (2023) 11 - p. 1415-1426 , 2023

Link: https://doi.org/10.1111/..

10

Real-World Safety and Efficacy of Biosimilar CT-P13 in Pati..:

Takeuchi, Tsutomu ; Nishikawa, Kiyohiro ; Yamada, Fumika...
Drug Safety. 46 (2023) 10 - p. 991-1005 , 2023

Link: https://doi.org/10.1007/..

11

43110 Deucravacitinib, a Selective Tyrosine Kinase 2 Inhibi..:

Tada, Yayoi ; Imafuku, Shinichi ; Okubo, Yukari...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB147 , 2023

Link: https://doi.org/10.1016/..

12

Long-term safety and efficacy of risankizumab for the treat..:

Papp, Kim A. ; Blauvelt, Andrew ; Puig, Lluís...
Journal of the American Academy of Dermatology. 89 (2023) 6 - p. 1149-1158 , 2023

Link: https://doi.org/10.1016/..

13

43872 Deucravacitinib, an Oral, Selective, Allosteric Tyros..:

Imafuku, Shinichi ; Okubo, Yukari ; Tada, Yayoi...
Journal of the American Academy of Dermatology. 89 (2023) 3 - p. AB147 , 2023

Link: https://doi.org/10.1016/..

14

Single‐center survey of incidental imaging findings on comp..:

Sugihara, Natsuko ; Kamiya, Koji ; Kado, Soichiro...
The Journal of Dermatology. 50 (2023) 8 - p. 1045-1051 , 2023

Link: https://doi.org/10.1111/..

15

Three cases of subcorneal pustular dermatosis with immunohi..:

Kishimoto, Megumi ; Komine, Mayumi ; Okada, Hirofumi...
The Journal of Dermatology. 50 (2023) 9 - p. 1150-1155 , 2023

Link: https://doi.org/10.1111/..